3 FTSE 100 stocks I’d sell today

These FTSE 100 (INDEXFTSE: UKX) stocks could disappoint investors, says Roland Head.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

When should you sell a stock? I think one good reason is when the risk of disappointment seems greater than the potential rewards on offer. In this piece, I’m going to look at three FTSE 100 stocks I think could disappoint investors over the next couple of years.

Takeaway profit

Online takeaway ordering service Just Eat (LSE: JE) is a leading player in this sector, with operations overseas as well as in the UK. But the firm is without a permanent chief executive, after former boss Peter Plumb departed suddenly in January after just 15 months in the job.

Plumb’s unexpected departure doesn’t fill me with confidence in the outlook for the firm. Indeed, several things worry me about this business.

Competition in this sector is rising fast. Companies such as Uber Eats and Deliveroo are changing the market. I think Just Eat’s profit margins could suffer in this environment.

Indeed, the firm’s profit margins aren’t that high to start with. In 2018, its operating margin was only 14%, which is much lower than dominant online marketplaces such as Rightmove and Auto Trader.

At about 640p, Just Eat shares trade on around 75 times 2019 forecast earnings. Analysts expect profits to double in 2020, but I’m not sure how confident we can be in such bold forecasts. In my view, the current share price carries a significant risk of disappointment.

Unhealthy figures?

Middle East private healthcare group NMC Health (LSE: NMC) operates a network of private hospitals in 19 Gulf countries.

Since floating on the London market in 2012, NMC has grown rapidly, helped by a string of acquisitions. However, this growth has come at a price. At the end of 2018, net debt was about $1.5bn, or 3.1 times earnings before interest, tax, depreciation and amortisation (EBITDA). That’s well above my preferred maximum of 2.0x.

I’m also concerned that, on average, it took the company 96 days to collect payment on customer bills last year. That seems high to me.

Adjusted earnings per share are expected to rise by about 23% in 2019, which may help to justify the stock’s price tag of 18 times forecast earnings. Personally, I think this business looks expensive when its debt burden is factored in. I think there are better choices elsewhere in the healthcare sector.

Fancy a flutter?

When bosses at Paddy Power Betfair decided to rename the group Flutter Entertainment (LSE: FLTR) earlier this year, they were hoping to resolve confusion about the group’s numerous different operating businesses. These include UK bookmakers, online sports betting, and European and US gaming activities.

Flutter’s UK profits took a hit last year, when new regulatory restrictions on fixed-odds betting terminals (FOBTs). Chief executive Peter Jackson is hoping to reignite growth by expanding in the US as sports betting is gradually legalised.

He’s also taking a punt on more lightly-regulated emerging markets — recent deals have included the acquisition of a betting company in Georgia.

In my view, this strategy carries a fair amount of risk. Competition will be intense in the US market and many states have yet to legalise sports betting. Regulation can also change unexpectedly in emerging markets.

Flutter shares currently trade on 19 times 2019 earnings and offer a yield of just 3.3%. That makes them more expensive than most rivals. I don’t think this premium is justified. I’d place my bets elsewhere in this sector.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has recommended Auto Trader, NMC Health, and Rightmove. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »

Investing Articles

3 top Vanguard ETFs to consider for an ISA or SIPP in 2026

Edward Sheldon believes that these three Vanguard ETFs could be solid investments for a pension (SIPP) or investment account in…

Read more »

Investing Articles

5 growth stocks on Dr James Fox’s watchlist for 2026

Dr James Fox believes these UK and US growth stocks are worth considering as he looks to outperform the stock…

Read more »